Abstract
We propose a mechanism that bilateral symmetry yields an entropic advantage for enzyme recognition. We suggest that bilateral symmetry may be a guiding principle used by nature to produce some particularly effective receptor–ligand interactions. An essential result is that bilateral symmetry is common among enzyme inhibitors, which coupled with an enhanced bond energy that connects dimer molecules compared to a reduced bond energy profile for higher oligomers provides a clue to explain the abundance of bilaterally symmetrical molecules found in Nature.
Similar content being viewed by others
References
Voloshchuk T, Farina NS, Wauchope OR, Kiprowska M, Haberfield P, Greer A (2004) J Nat Prod 67:1141
Bellarosa L, Zerbetto F (2003) J Am Chem Soc 125:1975
Bamford DG, Biggs DF, Chaplen P, Davis M, Maconochie JG (1971) Can J Pharm Sci 6:17
Descamps-François C, Yous S, Chavatte P, Audinot V, Bonnaud A, Boutin JA, Delagrange P, Bennejean C, Renard P, Lesieur D. (2003) J Med Chem 46:1127
Pauling L (1970) General Chemistry; W. H. Freeman Publishing Co., San Francisco, CA, p 398
Rekharsky MV, Inoue Y (1998) Chem Rev 98:1875
Acknowledgements
This research was supported in part by PSC-CUNY. O.R.W. is the recipient of the David Davidson Memorial Summer Research Award donated by Herbert and Estelle Meislich.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greer, A., Wauchope, O.R., Farina, N.S. et al. Paradigms and paradoxes: Mechanisms for possible enhanced biological activity of bilaterally symmetrical chemicals. Struct Chem 17, 347–350 (2006). https://doi.org/10.1007/s11224-006-9008-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11224-006-9008-2